154 related articles for article (PubMed ID: 12011969)
1. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
[TBL] [Abstract][Full Text] [Related]
2. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
Incandela L; Belcaro G; Renton S; DeSanctis MT; Cesarone MR; Bavera P; Ippolito E; Bucci M; Griffin M; Geroulakos G; Dugall M; Golden G; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S7-S10. PubMed ID: 12011966
[TBL] [Abstract][Full Text] [Related]
3. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
De Sanctis MT; Belcaro G; Incandela L; Cesarone MR; Griffin M; Ippolito E; Cacchio M
Angiology; 2001 Oct; 52 Suppl 2():S55-9. PubMed ID: 11666125
[TBL] [Abstract][Full Text] [Related]
4. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized study.
Incandela L; Cesarone MR; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S11-5. PubMed ID: 12011967
[TBL] [Abstract][Full Text] [Related]
5. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Stuard S; Corsi M
Angiology; 2005; 56(2):165-72. PubMed ID: 15793606
[TBL] [Abstract][Full Text] [Related]
6. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
7. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
[TBL] [Abstract][Full Text] [Related]
8. Flight microangiopathy in medium-to-long distance flights: prevention of edema and microcirculation alterations with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, randomized, controlled trial.
Cesarone MR; Belcaro G; Incandela L; Geroulakos G; Griffin M; Lennox A; DeSanctis MT; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S17-20. PubMed ID: 12011968
[TBL] [Abstract][Full Text] [Related]
9. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial.
Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S25-8. PubMed ID: 12011970
[TBL] [Abstract][Full Text] [Related]
10. Capillary filtration and ankle edema in patients with venous hypertension treated with TTFCA.
Belcaro GV; Rulo A; Grimaldi R
Angiology; 1990 Jan; 41(1):12-8. PubMed ID: 2305995
[TBL] [Abstract][Full Text] [Related]
11. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
12. Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins.
Cesarone MR; Belcaro G; Ricci A; Brandolini R; Pellegrini L; Dugall M; Di Renzo A; Vinciguerra G; Gizzi G; Cornelli U; Errichi BM; Corsi M; Ippolito E; Adovasio R; Cacchio M; Stuard S; Larnier C; Candiani C; Cerritelli F
Angiology; 2005; 56(3):289-93. PubMed ID: 15889196
[TBL] [Abstract][Full Text] [Related]
13. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
Ippolito E; Belcaro G; Dugall M; Cesarone MR; Feragalli B; Errichi BM; Gizzi G; Pellegrini L; Ledda A; Luzzi R; Ricci A; Bavera P; Hosoi M; Corsi M; Errichi S
Panminerva Med; 2011 Sep; 53(3 Suppl 1):13-9. PubMed ID: 22108472
[TBL] [Abstract][Full Text] [Related]
14. The LONFLIT4-Venoruton Study: a randomized trial--prophylaxis of flight-edema in venous patients.
Cesarone MR; Belcaro G; Brandolini R; Di Renzo A; Bavera P; Dugall M; Simeone E; Acerbi G; Ippolito E; Winford M; Candiani C; Golden G; Ricci A; Stuard S
Angiology; 2003; 54(2):137-42. PubMed ID: 12678187
[TBL] [Abstract][Full Text] [Related]
15. Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.
Petruzzellis V; Troccoli T; Candiani C; Guarisco R; Lospalluti M; Belcaro G; Dugall M
Angiology; 2002; 53(3):257-63. PubMed ID: 12025912
[TBL] [Abstract][Full Text] [Related]
16. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
[TBL] [Abstract][Full Text] [Related]
19. Flight microangiopathy on long-haul flights: prevention of edema and microcirculation alterations with Venoruton.
Cesarone MR; Belcaro G; Geroulakos G; Griffin M; Ricci A; Brandolini R; Pellegrini L; Dugall M; Ippolito E; Candiani C; Simeone E; Errichi BM; Di Renzo A
Clin Appl Thromb Hemost; 2003 Apr; 9(2):109-14. PubMed ID: 12812378
[TBL] [Abstract][Full Text] [Related]
20. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
